Soluble ST2 and Risk of Arrhythmias, Heart Failure, or Death in Patients with Mildly Symptomatic Heart Failure: Results from MADIT-CRT

Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view

(2016) Marcello Disertori et al.   Journal of Cardiovascular Medicine

Lessons learned from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT)

(2016) Valentina Kutyifa et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Why QRS Duration Should Be Replaced by Better Measures of Electrical Activation to Improve Patient Selection for Cardiac Resynchronization Therapy

(2016) Elien B. Engels et al.   Journal of Cardiovascular Translational Research

Soluble ST2 Testing in the General Population

(2015) Jennifer E. Ho et al.   AMERICAN JOURNAL OF CARDIOLOGY

ST2 Testing for Chronic Heart Failure Therapy Monitoring: The International ST2 Consensus Panel

(2015) James L. Januzzi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Biomarkers in electrophysiology: role in arrhythmias and resynchronization therapy

(2015) Abhishek Bose et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Prognostic Value of Soluble ST2 in the Valsartan Heart Failure Trial

(2014) Inder S. Anand et al.   Circulation-Heart Failure

Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15, and Highly-Sensitive Troponin T Measurements in Patients With Chronic Heart Failure

(2014) Hanna K. Gaggin et al.   JACC-Heart Failure

Biomarkers of Myocardial Stress and Fibrosis as Predictors of Mode of Death in Patients With Chronic Heart Failure

(2014) Tariq Ahmad et al.   JACC-Heart Failure

Soluble ST2 in Ambulatory Patients With Heart Failure

(2013) G. Michael Felker et al.   Circulation-Heart Failure

Biomarkers and Heart Disease: What is Translational Success?

(2013) Francis G. Spinale et al.   Journal of Cardiovascular Translational Research

ST2 as a Cardiovascular Risk Biomarker: From the Bench to the Bedside

(2013) James L. Januzzi   Journal of Cardiovascular Translational Research

Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology

(2012) Kaspar Broch et al.   EUROPEAN JOURNAL OF HEART FAILURE

Short term effect of CRT on biomarkers of cardiac remodelling and fibrosis: NT-proBNP, sST2, galectin-3, and a marker of oxidative stress — ceruloplasmin — A pilot study

(2012) Dagmar Vondráková et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Dyssynchrony, Contractile Function, and Response to Cardiac Resynchronization Therapy

(2011) Dorit Knappe et al.   Circulation-Heart Failure

Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure

(2011) Antoni Bayes-Genis et al.   EUROPEAN JOURNAL OF HEART FAILURE

High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart Failure

(2010) Bonnie Ky et al.   Circulation-Heart Failure

Risk stratification of ventricular arrhythmias in patients with systolic heart failure

(2010) Richard N Vest et al.   CURRENT OPINION IN CARDIOLOGY

Soluble ST2 for Predicting Sudden Cardiac Death in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction

(2009) Domingo A. Pascual-Figal et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

(2009) Arthur J. Moss et al.   NEW ENGLAND JOURNAL OF MEDICINE